FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007146553> ?p ?o ?g. }

• W2007146553 endingPage "e79096" @default.
• W2007146553 startingPage "e79096" @default.
• W2007146553 abstract "Background Metabolic syndrome has been shown to be associated with lower levels of plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP) in the general population. We sought to elucidate the relationship between Nt-proBNP and components of metabolic syndrome in patients with congestive heart failure (CHF). Methods Fasting blood samples were obtained from 93 patients in our institution. Plasma levels of Nt-proBNP and other biochemical data were measured. The New York Heart Association (NYHA) classification system (I-IV) was used to define the functional capacity of CHF. Metabolic syndrome and its components were defined using diagnostic criteria from the International Diabetes Federation. Results Forty-nine patients (52.7%) had CHF. There was a positive correlation between plasma Nt-proBNP levels and NYHA functional capacity in CHF patients. Plasma Nt-proBNP levels increased significantly with each increasing NYHA class of the disease. The prevalence of metabolic syndrome in CHF patients was higher than that in patients without CHF. Most importantly, we found that plasma Nt-proBNP levels were lower in CHF patients with metabolic syndrome attributable to inverse relationships between plasma Nt-proBNP and body mass index (β = −0.297), plasma triglyceride (β = −0.286) and homeostasis model assessment of insulin resistance (HOMA-IR; β = −0.346). Fasting glucose to insulin ratio (FGIR, an insulin sensitivity index) was positively associated with plasma Nt-proBNP levels (β = 0.491), and was the independent predictor of plasma Nt-proBNP levels in CHF patients. Conclusions Plasma Nt-proBNP levels are inversely associated with metabolic syndrome in CHF patients. Reduced plasma Nt-proBNP levels in CHF patients may lead to impaired lipolysis and metabolic function, and may contribute to the development of metabolic syndrome in CHF patients." @default.
• W2007146553 created "2016-06-24" @default.
• W2007146553 creator A5023189534 @default.
• W2007146553 creator A5037394444 @default.
• W2007146553 creator A5040837620 @default.
• W2007146553 creator A5050359900 @default.
• W2007146553 creator A5056928221 @default.
• W2007146553 creator A5072870305 @default.
• W2007146553 date "2013-11-12" @default.
• W2007146553 modified "2023-09-25" @default.
• W2007146553 title "Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure" @default.
• W2007146553 cites W191350524 @default.
• W2007146553 cites W1975790899 @default.
• W2007146553 cites W1976200721 @default.
• W2007146553 cites W1982166104 @default.
• W2007146553 cites W1983773915 @default.
• W2007146553 cites W1991413489 @default.
• W2007146553 cites W2004456062 @default.
• W2007146553 cites W2023559965 @default.
• W2007146553 cites W2024923203 @default.
• W2007146553 cites W2036714911 @default.
• W2007146553 cites W2041958692 @default.
• W2007146553 cites W2049832880 @default.
• W2007146553 cites W2051681689 @default.
• W2007146553 cites W2052043237 @default.
• W2007146553 cites W2057501387 @default.
• W2007146553 cites W2060125194 @default.
• W2007146553 cites W2076593268 @default.
• W2007146553 cites W2079577417 @default.
• W2007146553 cites W2098551866 @default.
• W2007146553 cites W2103714496 @default.
• W2007146553 cites W2109712401 @default.
• W2007146553 cites W2116983032 @default.
• W2007146553 cites W2118651999 @default.
• W2007146553 cites W2129095484 @default.
• W2007146553 cites W2130717716 @default.
• W2007146553 cites W2134293572 @default.
• W2007146553 cites W2144524915 @default.
• W2007146553 cites W2158504738 @default.
• W2007146553 cites W2160234571 @default.
• W2007146553 cites W4210956151 @default.
• W2007146553 cites W4253283824 @default.
• W2007146553 cites W57984565 @default.
• W2007146553 doi "https://doi.org/10.1371/journal.pone.0079096" @default.
• W2007146553 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3827135" @default.
• W2007146553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24265747" @default.
• W2007146553 hasPublicationYear "2013" @default.
• W2007146553 type Work @default.
• W2007146553 sameAs 2007146553 @default.
• W2007146553 citedByCount "16" @default.
• W2007146553 countsByYear W20071465532014 @default.
• W2007146553 countsByYear W20071465532015 @default.
• W2007146553 countsByYear W20071465532017 @default.
• W2007146553 countsByYear W20071465532018 @default.
• W2007146553 countsByYear W20071465532019 @default.
• W2007146553 countsByYear W20071465532021 @default.
• W2007146553 countsByYear W20071465532022 @default.
• W2007146553 countsByYear W20071465532023 @default.
• W2007146553 crossrefType "journal-article" @default.
• W2007146553 hasAuthorship W2007146553A5023189534 @default.
• W2007146553 hasAuthorship W2007146553A5037394444 @default.
• W2007146553 hasAuthorship W2007146553A5040837620 @default.
• W2007146553 hasAuthorship W2007146553A5050359900 @default.
• W2007146553 hasAuthorship W2007146553A5056928221 @default.
• W2007146553 hasAuthorship W2007146553A5072870305 @default.
• W2007146553 hasBestOaLocation W20071465531 @default.
• W2007146553 hasConcept C126322002 @default.
• W2007146553 hasConcept C134018914 @default.
• W2007146553 hasConcept C164705383 @default.
• W2007146553 hasConcept C2775915353 @default.
• W2007146553 hasConcept C2777180221 @default.
• W2007146553 hasConcept C2777391703 @default.
• W2007146553 hasConcept C2778198053 @default.
• W2007146553 hasConcept C2779306644 @default.
• W2007146553 hasConcept C2780221984 @default.
• W2007146553 hasConcept C2780578515 @default.
• W2007146553 hasConcept C2908647359 @default.
• W2007146553 hasConcept C511355011 @default.
• W2007146553 hasConcept C555293320 @default.
• W2007146553 hasConcept C71924100 @default.
• W2007146553 hasConcept C99454951 @default.
• W2007146553 hasConceptScore W2007146553C126322002 @default.
• W2007146553 hasConceptScore W2007146553C134018914 @default.
• W2007146553 hasConceptScore W2007146553C164705383 @default.
• W2007146553 hasConceptScore W2007146553C2775915353 @default.
• W2007146553 hasConceptScore W2007146553C2777180221 @default.
• W2007146553 hasConceptScore W2007146553C2777391703 @default.
• W2007146553 hasConceptScore W2007146553C2778198053 @default.
• W2007146553 hasConceptScore W2007146553C2779306644 @default.
• W2007146553 hasConceptScore W2007146553C2780221984 @default.
• W2007146553 hasConceptScore W2007146553C2780578515 @default.
• W2007146553 hasConceptScore W2007146553C2908647359 @default.
• W2007146553 hasConceptScore W2007146553C511355011 @default.
• W2007146553 hasConceptScore W2007146553C555293320 @default.
• W2007146553 hasConceptScore W2007146553C71924100 @default.
• W2007146553 hasConceptScore W2007146553C99454951 @default.
• W2007146553 hasIssue "11" @default.
• W2007146553 hasLocation W20071465531 @default.

• next